KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Return on Equity (2020 - 2025)

GoodRx Holdings (GDRX) has disclosed Return on Equity for 6 consecutive years, with 0.05% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 3.0% to 0.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.05% through Dec 2025, up 3.0% year-over-year, with the annual reading at 0.05% for FY2025, 2.0% up from the prior year.
  • Return on Equity hit 0.05% in Q4 2025 for GoodRx Holdings, down from 0.05% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.05% in Q2 2025 to a low of 0.45% in Q1 2021.
  • Historically, Return on Equity has averaged 0.07% across 5 years, with a median of 0.02% in 2024.
  • Biggest five-year swings in Return on Equity: tumbled -33bps in 2021 and later skyrocketed 43bps in 2022.
  • Year by year, Return on Equity stood at 0.03% in 2021, then tumbled by -36bps to 0.04% in 2022, then soared by 74bps to 0.01% in 2023, then surged by 314bps to 0.02% in 2024, then skyrocketed by 117bps to 0.05% in 2025.
  • Business Quant data shows Return on Equity for GDRX at 0.05% in Q4 2025, 0.05% in Q3 2025, and 0.05% in Q2 2025.